113 related articles for article (PubMed ID: 10494923)
1. A small breast cancer detected by PET.
Yasuda S; Kubota M; Tajima T; Tajima T; Umemura S; Fujii H; Takahashi W; Ide M; Shohtsu A
Jpn J Clin Oncol; 1999 Aug; 29(8):387-9. PubMed ID: 10494923
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
[TBL] [Abstract][Full Text] [Related]
3. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
Avril N; Rosé CA; Schelling M; Dose J; Kuhn W; Bense S; Weber W; Ziegler S; Graeff H; Schwaiger M
J Clin Oncol; 2000 Oct; 18(20):3495-502. PubMed ID: 11032590
[TBL] [Abstract][Full Text] [Related]
4. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
Baslaim MM; Bakheet SM; Bakheet R; Ezzat A; El-Foudeh M; Tulbah A
World J Surg; 2003 Oct; 27(10):1099-104. PubMed ID: 12917770
[TBL] [Abstract][Full Text] [Related]
5. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
Avril N; Adler LP
Radiol Clin North Am; 2007 Jul; 45(4):645-57, vi. PubMed ID: 17706529
[TBL] [Abstract][Full Text] [Related]
6. A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of
Oba T; Maeno K; Ono M; Iesato A; Ito T; Kanai T; Mochizuki Y; Ito KI; Yoshizawa A; Takayama F
Breast J; 2017 Mar; 23(2):220-224. PubMed ID: 28299890
[TBL] [Abstract][Full Text] [Related]
7. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
8. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Koolen BB; van der Leij F; Vogel WV; Rutgers EJ; Vrancken Peeters MJ; Elkhuizen PH; Valdés Olmos RA
Acta Oncol; 2014 Jan; 53(1):50-7. PubMed ID: 23672678
[TBL] [Abstract][Full Text] [Related]
10. Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.
Bakheet SM; Powe J; Ezzat A; Bakri Y
Clin Nucl Med; 1998 Sep; 23(9):616. PubMed ID: 9735987
[No Abstract] [Full Text] [Related]
11. Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E
Clin Radiol; 2008 Nov; 63(11):1213-27. PubMed ID: 18929039
[TBL] [Abstract][Full Text] [Related]
12. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Bassa P; Kim EE; Inoue T; Wong FC; Korkmaz M; Yang DJ; Wong WH; Hicks KW; Buzdar AU; Podoloff DA
J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314
[TBL] [Abstract][Full Text] [Related]
14. 18-fluorodeoxyglucose positron emission tomography in cystic carcinoma of the breast.
Baslaim MM; Bakheet SM; Ezzat A; Al Suhaibani H; Tulbah A
Breast J; 2002; 8(6):371-5. PubMed ID: 12390360
[TBL] [Abstract][Full Text] [Related]
15. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Schelling M; Avril N; Nährig J; Kuhn W; Römer W; Sattler D; Werner M; Dose J; Jänicke F; Graeff H; Schwaiger M
J Clin Oncol; 2000 Apr; 18(8):1689-95. PubMed ID: 10764429
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of SUV
Diao W; Tian F; Jia Z
Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
[TBL] [Abstract][Full Text] [Related]
18. Metastatic brachial plexopathy from breast cancer detected by 18F-FDG PET/MRI.
Treglia G; Paone G; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):54-5. PubMed ID: 23938189
[No Abstract] [Full Text] [Related]
19. The value of positron emission tomography in the follow-up for breast cancer.
Siggelkow W; Zimny M; Faridi A; Petzold K; Buell U; Rath W
Anticancer Res; 2003; 23(2C):1859-67. PubMed ID: 12820470
[TBL] [Abstract][Full Text] [Related]
20. Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Korn RL; Yost AM; May CC; Kovalsky ER; Orth KM; Layton TA; Drumm D
AJR Am J Roentgenol; 2006 Jul; 187(1):81-5. PubMed ID: 16794159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
